The JAK/STAT3 signalling pathway modulates cancer cell survival, proliferation, migration, invasion, angiogenesis, lymphangiogenesis and immune evasion in many types of cancers, such as prostate cancer, gastric cancer, and hepatocellular carcinoma 16, 17, 18. The gene discussed is STAT3; the disease is gastric cancer.